Compares two nerve block approaches for pain after weight-loss surgery
Compares one-level and two-level nerve blocks for pain in adults having bariatric surgery.
Plain-language title generated from the registry record
Registry title: Bilateral Thorathic Erector Spinae Plane Block in Laparoscopic Bariatic Surgeries
Key facts
- Where
- Cairo, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Source: NCT06812364, who can take part
Where in Egypt
- Faculty of Medecine Cairo UneversityCairo, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Cairo University
- Trial code
- NCT06812364
- Record updated
- 6 February 2025
- Original description
The study is to evaluate effectiveness of one-level versus two-level thoracic ESP block on intraoperative and postoperative analgesia in bariatric surgeries and to compare total opioid consumption of both groups.Read full original descriptionShow less
COMPARISON OF THE EFFICACY OF ONE LEVEL AND TWO LEVEL OF BILATERAL THORACIC ERECTOR SPINAE PLANE BLOCK COMBINED WITH GENERAL ANESTHESIA IN LAPAROSCOPIC BARIATRIC SURGERY FOR OBESE PATIENTS: RANDOMIZED CONTROLLED TRIAL
The study is to evaluate effectiveness of one-level versus two-level thoracic ESP block on intraoperative and postoperative analgesia in bariatric surgeries and to compare total opioid consumption of both groups.
Inclusion: Patient age ranges 18 to 60 years old; Obese patients ; Body mass index(BMI) ≥ 35 - 50 kg/m2; American Society of Anesthesiologists (13) physical status classes II to III; Patients scheduled for laparoscopic bariatric surgery i.e. sleeve gastrectomy and/or Roux-en-Y gastric bypass (RYGB) surgeries.
Exclusion: • Refusal of regional block; Patients with neurological, psychological disorders or those lacking cooperation; Patients scheduled for concomitant laparoscopic cholecystectomy or paraumbilical hernia repair or those with history of previous bariatric surgery or obstructive sleep apnea; Patients with anatomic abnormalities at site of injection, skin lesions or wounds at site of proposed needle insertion; Patients with bleeding disorders defined as (INR >1.4) and/ or (platelet count <100,000/µL); Patients with hepatic disease e.g. liver cell failure or hepatic malignancy or hepatic enlargement; Patients who are allergic to amide local anesthetics.